Rx Minute: Implementation of Medicare Part D Followed by Significant Reductions in Nondrug Medical Spending

new study published in the Journal of the American Medical Association (JAMA) finds that implementation of the Medicare prescription drug plan in 2006 was followed by significant decreases in spending on nondrug medical expenditures among beneficiaries who previously had limited drug coverage. After Medicare Part D started, nondrug medical spending in this group was about $1,200 per year less than expected.

Rx Minute: Insurance Coverage for Chronically Ill Less Generous

recent study found that insurance coverage for chronically ill patients is less generous than those without a chronic condition, primarily due to higher cost sharing for prescription drugs. 

“We Work for Health” Champions

04.11.13 | By

There is certainly no lack of talent in the biopharmaceutical industry. Every day, employees are working hard in a variety of roles to ensure that patients get the treatments they need. It isn’t just the research scientists in the lab, it’s sales executives and communications staff who go above and beyond to advance research, progress and hope in everything they do.

Rx Minute: Statins Value to Society & Risk Factors Linked to Alzheimer's

A recent article published in Health Affairs highlights the remarkable impact of cholesterol-lowering drugs known as statins on the treatment of cardiovascular disease in the U.S.

Research Key to Medical “Miracles”

04.11.13 | By

The second #PhRMA13 panel begins at 1:45 pm EDT and will address medical breakthroughs and what needs to change to speed personalized medicine to patients. In a guest post, John Crosby, Executive Director at the American Osteopathic Association, addresses what he believes is necessary to bring science from the lab to the patient.

Pivotal Time for U.S. Biopharmaceutical Industry

04.11.13 | By

PhRMA Chairman and Lilly President and CEO John Lechleiter is kicking off #PhRMA13 now. In a guest post he discusses the future of the industry. To learn more watch live now!

For decades, San Diego has been at the center of the biotech revolution. The advances pioneered by scientists in the San Diego area have had a dramatic impact on human well-being and longevity. 

New PhRMA.org Launches Just in Time For #PhRMA13

04.11.13 | By

As we gear up for discussion today around research, progress and hope at our 2013 Annual Meeting in San Diego, we are enthusiastic about the re-launch of our website, PhRMA.org. With the goal of extending PhRMA’s online reach, the site is the central hub for our digital and social media communications efforts and represents a big step forward in our overall program.

PhRMA Statement on President’s 2014 Budget

 WASHINGTON, D.C. (April 10, 2013) – Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Matthew Bennett issued the following statement today:

“President Obama has pressed for innovation and biomedical research, job creation, and controlling health care costs and yet his 2014 budget includes stale, previously rejected proposals that would undercut all of these efforts.  Notably, not one of these policies was included in the budget blueprints already passed by the House and the Senate. 

When Social Media and Traditional Media Meet

Today is a big day at Lilly. Not only does our CEO, John Lechleiter, begin chairing the PhRMA annual meeting, but we’re also launching a new digital communications platform that will enhance our conversations with media who cover the biopharmaceutical industry.

PhRMA Statement on President’s 2014 Budget


Subscribe to RSS - Opinion